Overview

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of AML patients by observing the factors related to the efficacy and adverse reactions.
Phase:
Phase 2
Details
Lead Sponsor:
Anhui Provincial Hospital
Treatments:
Azacitidine
Venetoclax